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Abstract In this study we have examined the effect of the
SNARE protein syntaxin 1A on the glycine transporters GLYT1
and GLYT2. Our results demonstrate a functional and physical
interaction between both glycine transporters and syntaxin 1A.
Co-transfection of syntaxin 1A with GLYT1 or GLYT2 in COS
cells resulted in approximately 40% inhibition in glycine
transport. This inhibition was reversed by the syntaxin 1A-
binding protein, Munc18. Furthermore, immunoprecipitation
studies showed a physical interaction between syntaxin 1A and
both transporters in COS cells and in rat brain tissue. Finally, we
conclude that this physical interaction resulted in a partial
removal of the glycine transporters from the plasma membrane
as demonstrated by biotinylation studies.
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1. Introduction
Glycine is an inhibitory neurotransmitter mainly present in
the spinal cord and the brain stem, where it plays a role in a
variety of motor and sensory functions. Moreover, glycine
modulates the action of glutamate on the N-methyl-D-aspar-
tate receptors. After the release of glycine and its binding to
postsynaptic receptors, high a⁄nity reuptake mechanisms
play an important role in the removal of glycine from the
extracellular space, thereby terminating the neurotransmission
signal. The ¢ne-tuning of this reuptake mechanism is thought
to control the duration of the neurotransmission signal and
therefore the overall synaptic action.
Reuptake of glycine from the intersynaptic space is modu-
lated by high a⁄nity glycine transporters. Two glycine trans-
porters have been cloned: GLYT1 and GLYT2. The cDNAs
encoding GLYT1 and GLYT2 have been used for extensive
research on these transporters. The subjects of these studies
have been N-glycosylation, localization, and structure^func-
tion relationships [1,2]. Concerning the important role neuro-
transmitter transporters have in neurotransmission it seems
obvious that they must be properly regulated. However, not
much is known about the regulation of the glycine transport-
ers. Previously it was found that activation of protein kinase
C (PKC) by phorbol esters resulted in an inhibition of glycine
transport [3]. So far, this has been the only regulation mech-
anism described for the glycine transporters.
Syntaxin 1A is a plasma membrane protein from the
SNARE system which regulates intracellular membrane traf-
¢cking [4]. Furthermore, it has a role in the regulation of
several ion channels (e.g. Ca2 and the CFTR Cl3 channels,
[5] and [6], respectively) and the Q-aminobutyric acid (GABA)
transporter GAT1 [7]. For this GABA transporter, which be-
longs to the same family of sodium-dependent neurotransmit-
ter transporters as the glycine transporters, it was found that
it interacts directly with syntaxin 1A and that this interaction
is regulated by PKC [7].
In our ongoing research on the function and regulation of
the glycine transporters we became interested in the regulation
of glycine transporters by SNARE proteins. Here we report
that syntaxin 1A regulates and interacts directly with the neu-
ronal glycine transporters GLYT1 and GLYT2.
2. Materials and methods
2.1. Materials
COS-7 cells were from American Type Culture Collection (Manas-
sas, VA, USA). Antibodies against syntaxin 1A, SNAP-25 and
Munc18 were obtained from Upstate Biotechnology (Lake Placid,
NY, USA), Stressgen (Victoria, Canada) and Transduction Labora-
tories (Lexington, KY, USA), respectively. GLYT1 and GLYT2 anti-
bodies have been characterized [8].
2.2. cDNA constructs
The cDNAs encoding syntaxin 1A, Munc18a and SNAP-25 were
PCR ampli¢ed from a rat brain cDNA library using the following
PCR primers: ccgaattccatgaaggaccgaacccaggagctccgc and gggaattcc-
tatccaaagatgcccccgatggtggagg for syntaxin 1A; cgaattccgccatggcccc-
cattggcctc and tgaattcgggcagctgattttaactgcttatttcttcg for Munc18a;
cacgaattccatggccgaggacgcagacatgcg and aggcttaagttaaccacttcccagca-
tctttg for SNAP-25. The PCR products were cloned into pcDNA3
(Invitrogen), and sequenced completely. The cDNA encoding syntaxin
1A was cloned into pcDNA3 in both the sense and antisense direc-
tions. The cDNA constructs of GLYT1b and GLYT2a in pcDNA3
have been described [9].
2.3. Cell transfection
Transfection of COS cells was carried out using LipofectAMINE
(Life Technologies) in serum free Dulbecco’s modi¢ed Eagle’s medium
(DMEM). Reproducible results were obtained when transfections
were performed with 50% con£uent cells on a 60 mm petri dish using
2 Wg of total DNA. The total DNA consisted of 0.5 Wg of each cDNA
construct completed with pcDNA3 plasmid up to 2 Wg. The lipid/
DNA mixture was incubated with the cells for 3 h. Subsequently cells
were rinsed and re-fed with DMEM complemented with 10% fetal calf
serum. Forty-eight hours after transfection cells were assayed for gly-
cine uptake.
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2.4. Uptake assays
Transport assays in transfected COS cells were performed at 37‡C
in HEPES-bu¡ered saline as described [2]. All incubations were per-
formed in triplicate using 10 WM radiolabeled glycine (DuPont). The
incubation period was always 6 min. Protein concentrations were
determined by the method of Bradford [10]. Where indicated, the
transfected cells were preincubated for 1 h at 37‡C in HEPES-bu¡ered
saline in the presence or absence of 1 mM glycine.
2.5. Immunoblots and immunoprecipitation
SDS^PAGE and Western blotting have been described [2]. Co-im-
munoprecipitation using a protein extract from transfected COS cells
or from rat brain tissue was done in the following lysis bu¡er: 50 mM
HEPES (pH 7.4), 150 mM NaCl, 5 mM EDTA, 1% Triton X-100,
and 0.2 mM phenylmethylsulfonyl £uoride. Where indicated, 1 mM
glycine was added to the lysis bu¡er. The protein extract from whole
rat brain was obtained using a glass homogenizer. Cell debris was
removed by centrifugation. 50 Wg of protein was incubated with
GLYT1 or GLYT2 antibodies for 3 h in 1 ml lysis bu¡er, followed
by the addition of 30 Wl of a 50% slurry of protein A-Sepharose beads.
After an additional 1 h incubation, the beads were washed three times
with 1 ml lysis bu¡er. The proteins were then eluted from the beads
with Laemmli sample bu¡er and subjected to Western blotting with
the indicated antibody.
2.6. Cell surface labeling
Cell surface proteins of transfected COS cells were labeled with the
cell membrane impermeable reagent sulfo-N-succinimidyl-6-biotinami-
do hexanoate as described [11]. In brief, cells were washed with phos-
phate-bu¡ered saline (PBS) and incubated for 30 min on ice in the
presence of 1.5 mg/ml sulfo-N-succinimidyl-6-biotinamido hexanoate
in PBS. Then, cells were washed, and the excess of reagent was
quenched with 10 mM lysine in PBS for 10 min. Cells were lysed in
immunoprecipitation bu¡er (150 mM NaCl, 50 mM HEPES^Tris,
5 mM EDTA, 1% Triton X-100, 0.25% deoxycholate, 0.1% sodium
dodecyl sulfate, pH 7.4), and biotinylated proteins were precipitated
with agarose^streptavidin. Precipitated proteins were fractionated by
SDS^PAGE and analyzed by Western blotting. Quantitation of pro-
tein bands was performed on a densitometer model 300A in combi-
nation with Image Quant software (Molecular Dynamics).
3. Results
3.1. Syntaxin 1A functionally regulates GLYT1 and GLYT2 by
a direct physical interaction
To test the hypothesis that syntaxin 1A functionally regu-
lates glycine transporters, glycine transport was assayed in
COS cells expressing GLYT1 or GLYT2 with or without
co-expression of syntaxin 1A. Both glycine transporters and
the SNARE proteins used in this study (syntaxin 1A, SNAP-
25 and Munc18) were expressed well in these cells, as assessed
from immunoblots with speci¢c antibodies. Moreover, no en-
dogenous signals for these proteins were observed in untrans-
fected cells (data not shown). We chose to assay glycine trans-
port at 10 WM glycine because at this concentration the non-
speci¢c transport of glycine is low compared to speci¢c trans-
port. At 10 WM glycine, speci¢c transport is typically 5^10
times higher in transfected COS cells compared to untrans-
fected cells. This may be explained by the di¡erences in Km
value between speci¢c and non-speci¢c glycine transport; the
Km value for non-speci¢c transport is around 10 times higher
than speci¢c transport in COS cells (unpublished data). Ex-
pression of syntaxin 1A never a¡ected non-speci¢c glycine
transport in COS cells, which was always subtracted from
the speci¢c transport. We observed a substantial inhibition
(around 40%) of glycine transport in both transporter iso-
forms (GLYT1 and GLYT2) when syntaxin 1A was co-ex-
pressed (Fig. 1A,B). This inhibition was not observed when
an antisense construct of syntaxin 1A was used for transfec-
tion (data not shown).
To show that syntaxin 1A did not alter the expression of
the glycine transporters, we extracted in each experiment total
GLYT1 and GLYT2 proteins from the transfected COS cells
and performed Western blot analysis. Typical results are
shown in Fig. 1C,D. As has been described previously [8],
glycine transporters transiently expressed in COS cells show
a non-mature protein band, and a fully glycosylated mature
form which immunoreacts with either GLYT1 or GLYT2
antibodies. The fully processed transporters are shown in
Fig. 1C,D, indicating that neither transfection levels nor gly-
cine transporter expression seem to be changed by syntaxin
1A co-expression.
The inhibition of glycine transport by syntaxin 1A was
reversed by co-expression of the syntaxin-binding protein
Munc18 (Fig. 1A,B). Munc18 binds tightly to syntaxin 1A
and in this manner prevents the binding of syntaxin 1A to
other binding partners [12]. Probably this also holds for the
glycine transporters, resulting in a rescuing of the syntaxin 1A
inhibition. This result additionally proves that the inhibitory
e¡ect of syntaxin 1A is not due to translational competition
causing the reduction in glycine transport.
Fig. 1. The glycine transporters GLYT1 (A, n = 7) and GLYT2 (B, n = 6) are functionally inhibited by syntaxin 1A. This inhibition is reversed
by co-expression of the syntaxin 1A-binding protein Munc18. Immunoblots with speci¢c antibodies against GLYT1 (C) and GLYT2 (D) dem-
onstrate that syntaxin 1A does not a¡ect GLYT1 or GLYT2 expression. The bands shown are from the mature glycosylated GLYT1 and
GLYT2 proteins.
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The functional data suggested an interaction between syn-
taxin 1A and GLYT1 and GLYT2. To test this hypothesis we
performed co-immunoprecipitation studies in which we used
COS cells transfected with syntaxin 1A together with GLYT1
or GLYT2. We also used COS cells transfected only with
syntaxin 1A as a control. The results of these studies, in which
we used GLYT1 or GLYT2 antibodies for immunoprecipita-
tion and syntaxin 1A antibodies in the subsequent Western
analysis, are shown in Fig. 2A^E. Both GLYT1 and GLYT2
antibodies co-immunoprecipitate syntaxin 1A, but not in COS
cells transfected only with syntaxin 1A. These results demon-
strate that a physical interaction exists between the glycine
transporters and syntaxin 1A in transfected COS cells. To
test if this physical interaction also exists in brain tissue, we
performed co-immunoprecipitation using a protein extract
from rat brain tissue under the same conditions. The results
show that the same physical interactions exist in this tissue,
additionally indicating a possible physiological role for the
interaction (Fig. 2F^H).
3.2. Syntaxin 1A controls the number of glycine transporters on
the plasma membrane
The inhibitory e¡ect of syntaxin 1A could result from an
e¡ect on the glycine transporter (e.g. conformational changes)
or from a reduction in the number of plasma membrane-res-
ident glycine transporters. To address this issue we performed
two di¡erent types of experiments: kinetic analysis and sur-
face biotinylation studies.
The kinetic parameters Km and Vmax for both glycine trans-
porters in the presence and absence of syntaxin 1A are pre-
sented in Table 1. Although a small change in the Km value
was detected for GLYT1, co-expression with syntaxin 1A
mainly resulted in a lower Vmax value for both transporters.
This change in maximum velocity of transport might be ex-
plained by a change in the number of transporter-binding sites
present on the plasma membrane. Surface biotinylation stud-
ies revealed changes in surface GLYT1 and GLYT2 immu-
noreactivities (Fig. 3). Both transporters were less present on
the cell surface when co-expressed with syntaxin 1A. Impor-
tantly, this e¡ect was reversed by Munc18. On the other hand,
the non-biotinylated but fully processed (internal) transporters
were more abundant when syntaxin 1A was co-expressed with
GLYT1 or GLYT2.
The results from both the biotinylation and the kinetic ex-
periments show that syntaxin 1A inhibits glycine transport by
interfering with the delivery and/or the removal of GLYT1
and GLYT2 to and/or from the plasma membrane.
3.3. Glycine and SNAP-25 do not alter the syntaxin^
transporter interaction
L-type, N-type and P/Q-type Ca2 channels are functionally
regulated by the SNARE proteins syntaxin 1A and SNAP-25
[13,14]. So we became interested to see if the glycine trans-
porters also interacted with SNAP-25. For this, we co-trans-
fected COS cells either with GLYT1 or GLYT2, together with
SNAP-25, or with the combination syntaxin 1A and SNAP-
25. Subsequently, glycine transport was measured in these
cells. Our results indicated that SNAP-25 had no functional
e¡ect on transport when expressed alone and no additional
e¡ect in combination with syntaxin was detected (data not
shown). Furthermore, we were not able to co-immunoprecipi-
tate SNAP-25 using Ig-GLYT1 and Ig-GLYT2 in transfected
COS cells or in rat brain extract (data not shown). So SNAP-
25 seems not to have a direct interaction with the glycine
transporters.
The GABA transporter was found to be regulated by ex-
tracellular GABA, and it was suggested that this regulation
Fig. 2. Co-immunoprecipitations demonstrate that physical interac-
tions exist between GLYT1 and GLYT2 with syntaxin 1A in trans-
fected COS cells and in rat brain tissue. Immunoblots stained with
Ig-syntaxin 1A: protein extract of COS cells expressing syntaxin 1A
(A), COS cells expressing syntaxin 1A were immunoprecipitated
with Ig-GLYT1 (B), as B using Ig-GLYT2 for immunoprecipitation
(C), COS cells expressing syntaxin 1A together with GLYT1 were
immunoprecipitated with Ig-GLYT1 (D), COS cells expressing syn-
taxin 1A together with GLYT2 were immunoprecipitated with Ig-
GLYT2 (E), protein extract of rat brain (F), rat brain extract im-
munoprecipitated with Ig-GLYT1 (G), rat brain extract immunopre-
cipitated with Ig-GLYT2 (H).
Table 1
Kinetic data of the glycine transporters GLYT1 and GLYT2 in the




(pmol mg31 6 min31)
GLYT1 85.0 þ 3.0 26.4 þ 0.8
GLYT1+syntaxin 1A 65.0 þ 1.3 14.2 þ 0.3
GLYT2 75.1 þ 16.5 3.6 þ 0.7
GLYT2+syntaxin 1A 82.9 þ 13.3 2.3 þ 0.3
Fig. 3. Cell surface biotinylation shows that syntaxin 1A controls
the number of glycine transporters on the plasma membrane in
transfected COS cells. This e¡ect is reversed by Munc18. A: Glycine
transporter. B: Glycine transporter co-expressed with syntaxin 1A.
C: Glycine transporter co-expressed with syntaxin 1A and Munc18.
Quantitation of surface GLYT1 and GLYT2 as percentage of total
protein is shown in the graphs.
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might be due to an alteration in the interaction of the trans-
porter with syntaxin 1A [15]. To test if glycine alters the
interaction between the glycine transporters and syntaxin 1A
we performed co-immunoprecipitation studies using rat brain
tissue in the presence and absence of 1 mM glycine. We did
not observe any di¡erences between the co-immunoprecipita-
tions for GLYT1 and GLYT2 with syntaxin 1A in the pres-
ence or absence of glycine (data not shown). We also observed
no di¡erences in the inhibition of both glycine transporters
caused by syntaxin 1A when transfected COS cells were pre-
incubated for 1 h with or without 1 mM glycine (data not
shown). These results indicate that glycine does not alter the
interaction of syntaxin 1A with the glycine transporters under
the conditions used.
4. Discussion
We used COS cells as an expression system to explore the
role of the SNARE protein syntaxin 1A on the glycine trans-
porters GLYT1 and GLYT2. The principal ¢ndings of the
studies include: (1) both glycine transporters can be function-
ally modulated by syntaxin 1A, (2) the glycine transporters
physically interact with syntaxin 1A both in transfected cells
and in brain tissue, (3) syntaxin 1A decreases the number of
GLYT1 and GLYT2 proteins on the plasma membrane, but
does not a¡ect the overall expression of glycine transporters,
(4) Munc18 reverses the inhibition caused by syntaxin, (5)
SNAP-25 seems not to participate in the regulation, and (6)
glycine does not change the interaction between syntaxin 1A
and the glycine transporters.
Syntaxin 1A is a SNARE protein involved in the intracel-
lular membrane tra⁄cking pathways [4]. Our results show
that co-expression of syntaxin 1A with both glycine transport-
ers results in fewer transporter proteins on the plasma mem-
brane as compared to control cells not expressing syntaxin
1A. Most likely, syntaxin 1A somehow interferes with the
tra⁄cking of the transporters to and/or from the plasma
membrane. Although the exact mechanism by which syntaxin
acts is yet unknown, it seems reasonable to think that syntax-
in 1A controls the number of glycine transporter molecules on
the plasma membrane by a direct physical contact, regulating
in this way neurotransmitter transport. Future studies should
clarify how syntaxin plays its role, and how syntaxin itself is
regulated in order to function in both exocytosis and neuro-
transmitter reuptake.
The glycine transporters GLYT1 and GLYT2 share respec-
tively 41 and 48% homology with the GABA transporter.
Nevertheless, these transporters behave very similarly in their
interaction with syntaxin 1A. The GABA transporter was also
found to interact directly with syntaxin 1A resulting in an
inhibition of GABA transport [16]. Moreover, PKC is in-
volved in this interaction [16], and modulates a re-localization
of the transporter from intracellular pools to the plasma mem-
brane [7]. Concerning the growing number of membrane pro-
teins which have interaction with syntaxin 1A, it becomes
more and more obvious that syntaxin 1A acts as a general
regulator in plasma membrane protein tra⁄cking, something
that was mentioned before [17].
Syntaxin 1A is broadly distributed throughout the central
and peripheral nervous systems on synaptic terminal mem-
branes [18]. GLYT2 is present in the spinal cord, brain stem
and cerebellum, whereas GLYT1 has a broader distribution
[8]. The co-localization together with the data presented here
opens new possibilities for studying the regulation of the gly-
cine transporters.
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